help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeLucia, M. C.
Right arrow Articles by Carpenter, T. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeLucia, M. C.
Right arrow Articles by Carpenter, T. O.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 8 3539-3545
Copyright © 2003 by The Endocrine Society

Nutritional Rickets with Normal Circulating 25-Hydroxyvitamin D: A Call for Reexamining the Role of Dietary Calcium Intake in North American Infants

Maria C. DeLucia, MaryAnn E. Mitnick and Thomas O. Carpenter

Departments of Pediatrics (Endocrinology) (M.C.D., T.O.C.) and Internal Medicine (Endocrinology) (M.E.M.), Yale University School of Medicine, New Haven, Connecticut 06520-8064

Address all correspondence and requests for reprints to: Thomas O. Carpenter, M.D., Yale University School of Medicine, 333 Cedar Street, 3103 LMP, P.O. Box 208064, New Haven, Connecticut 06520-8064. E-mail: thomas.carpenter{at}yale.edu.


    Abstract
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Case Reports
 Discussion
 References
 
The incidence of nutritional rickets appears to be increasing in North American infants and toddlers; it is widely assumed that this is due to vitamin D deficiency. Thus, records of 43 children with nutritional rickets from greater New Haven, Connecticut, from 1986–2002 were identified. The mean age of presentation was 20 months; 86% were of African-American, Hispanic, or Middle Eastern descent. More than 93% of children had been breastfed; however, 15% had received vitamin D supplementation. Eighty-six percent of those with food histories available were weaned to diets with minimal dairy content after nursing. Serum 25-hydroxyvitamin D was 20.9 ± 11.5 ng/ml and was less than 15 ng/ml in only 22% of patients. Three representative case histories suggest that dietary calcium intake may play a contributory role in the development of disease; 1 case documents radiographic and biochemical resolution of rachitic abnormalities after calcium treatment, but no vitamin D therapy. Clinicians should be aware that low dietary calcium intake after weaning may result in the development of nutritional rickets, and that attention to calcium intake as well as that of vitamin D is important in the establishment of optimal dietary practices for North American infants and children.


    Introduction
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Case Reports
 Discussion
 References
 
NUTRITIONAL RICKETS HAS been increasingly reported in recent years, particularly among vulnerable populations of children (1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11). Vitamin D deficiency is widely assumed to be the primary cause of this disorder. Inadequate vitamin D acquisition through either poor dietary intake or limited sunlight exposure leads to depletion of vitamin D stores, with resultant decreased calcium absorption in the small intestine, thereby decreasing the available calcium for epiphyseal cartilage and skeletal mineralization. Limited calcium availability with resultant secondary hyperparathyroidism and attendant renal phosphate losses contribute to the bone and growth plate pathophysiology that lead to the clinical manifestations of rickets.

Historical features associated with nutritional rickets include lengthy duration of breastfeeding, absence of vitamin supplementation, limited sunlight exposure, dark skin pigmentation, and limited intake of dairy products, particularly those supplemented with vitamin D. The recent increase in reported cases may reflect an increasing influence of these factors. Considerable public health efforts have resulted in an increased number of infants being breastfed (12); this expanded practice of breastfeeding may have unintentionally increased the number of infants at risk for the development of rickets, as there is minimal vitamin D present in breast milk (13). However, another potential contributor to the development of nutritional rickets is the diet to which infants are weaned after breastfeeding. Unfortified juices, which are high in carbohydrates and lacking in calcium and other key bone nutrients, have replaced milk in the diets of many children (14). As a result, appropriate dietary intake of calcium, vitamin D, protein, and other nutrients important for the maintenance of skeletal health may be lacking.

To characterize the clinical features of children presenting with rickets in the greater New Haven, Connecticut, population, we retrospectively reviewed the records of such patients as encountered at the Yale-New Haven Hospital clinics over the past several years. Data from all patients as well as three cases representing the influence of calcium therapy are presented.


    Subjects and Methods
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Case Reports
 Discussion
 References
 
Chart review

The records of 134 children with the diagnostic code of rickets at our institution from 1986–2002 were reviewed. Of these, 43 children were considered to have nutritional rickets based upon characteristic clinical features, elevated serum alkaline phosphatase activity, and other typical biochemical abnormalities, and all had radiographic evidence of rickets. Children with a nutritional deficiency secondary to another disease (i.e. inherited bone disease, celiac disease, cystic fibrosis, renal disease, or hepatobiliary disorders) or rickets secondary to genetic or other nonnutritional etiologies were excluded.

Available demographic information, including age, gender, and racial/ethnic background, was identified. Information available regarding dairy intake was recorded. Details of duration of breastfeeding and vitamin supplementation were usually recorded. Physical features, as documented in the medical record, were obtained, including leg bowing, wrist/ankle splaying, rachitic rosary, and frontal bossing. Height and weight measurements were documented.

Laboratory evaluation of the children occasionally differed on a case to case basis due to delays in referral and initiation of therapy after telephone consultation with a specialty physician. Therefore, any laboratory values obtained after application of therapy were not included in the analysis. The actual number of cases in which assays were performed are described in Results for each biochemical variable. Likewise, if the onset of therapy preceded evaluation at the Yale-New Haven Hospital, clinical data for presenting signs were not analyzed, and the number of evaluated children for clinical variables is included in Results. Finally, because of differences in referred and institutional assays, PTH levels are reported as a percentage of the upper limit of normal for the assay.

All radiographs had been evaluated by a board-certified pediatric radiologist. Evidence of impaired mineralization, frayed epiphyses, and/or metaphyseal widening on radiographs were observed in all cases and were considered consistent with rickets.

These activities were approved by the human investigation committee of Yale University School of Medicine and were considered to be appropriate with respect to the treatment of human subjects.

Analytic methods

Serum and urinary biochemical determinations were performed by the Clinical Chemistry Laboratory of Yale-New Haven Hospital. Total serum calcium was determined by flame atomic absorptiometry (model 2380, PerkinElmer, Norwalk, CT). Serum magnesium, phosphorus, alkaline phosphatase, and blood urea nitrogen were measured using standard autoanalyzer technology.

Serum PTH and, in most cases (19 of 26), vitamin D metabolites were measured by the Yale Mineral Metabolism Laboratory; the serum immunoreactive PTH concentration was measured with antisera to the midregion of human PTH using the 125I-labeled 37–84 residue fragment of bovine PTH as a radioactive trace and standards from a human PTH adenoma extract as previously described (15). The sensitivity of this assay is 1 nlEq/ml; the intra- and interassay coefficients of variation are 3.9% and 5.4%, respectively. Normal values are 10–25 nlEq/ml.

Circulating 25-hydroxyvitamin D (25-OHD) levels were measured after alcohol extraction by competitive protein binding assay, using rat plasma as the source of vitamin D-binding protein (16). The intra- and interassay coefficients of variation are 5.8% and 6.8%, respectively; the sensitivity of this assay is 0.25 ng/ml (0.6 nmol/liter); and the percent recovery is 90.8 ± 2.1%. Seven 25-OHD measurements were performed at Quest Laboratories (Norwich, NY). The intra- and interassay coefficients of variation of the Quest assay are less than 8% and less than 12%, respectively; the reported sensitivity of this assay is 1.2 ng/ml. In agreement with recent literature (17) we have interpreted values greater than 15 ng/ml (>37.5 nmol/liter) as indicative of vitamin D sufficiency. Circulating 1,25-dihydroxyvitamin D (1,25-OH2D) values were determined by competitive protein binding assay, with calf thymus receptor used for 1,25-OH2D, as described previously (18). The assay sensitivity is 5–6 pg/ml (12.0–14.4 nmol/liter); intra- and interassay coefficients of variation are 7% and 12%, respectively. Normal values in young children range from 30–90 ng/ml (72–216 pmol/liter).


    Results
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Case Reports
 Discussion
 References
 
All children in this series demonstrated clinical, biochemical, and radiographic evidence of rickets, and all had multiple historical features associated with the development of nutritional rickets. Demographic characteristics are listed in Table 1Go. The average age of presentation was 20.2 ± 8.2 months (range, 4–38); boys and girls were equally affected. Four children were international adoptees (3 from Eastern Europe and 1 from China). Seventy-nine percent of the total number of cases were African-American. Among native-born children, over 87% were African-American. Assessment of breastfeeding history, dairy intake, and vitamin D supplementation was by parental report, as specifically noted in the patient’s chart by the clinician. Over 96% (32 of 33) of children with a history of breastfeeding had been breastfed for more than 6 months. The average length of breastfeeding was 13.2 ± 5.5 months (range, 3.5–31). Thirteen children were breastfeeding to some degree at the time of presentation. Of those children who were no longer breastfeeding, the average length of time since cessation of breastfeeding was 9.5 ± 6.2 months (range, 0.5–22). Eighty-three percent (30 of 36) were weaned to a diet low in dairy products. Fifteen percent (5 of 34) had received vitamin D supplementation. All but 2 infants of 35 wk gestation were born at term.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Demographic features of the study population

 
Presenting signs are listed in Table 2Go. Eight percent (3 of 37) of the children presented with hypocalcemic tetany or seizure, and 31% (10 of 32) patients were resistant to weight bearing. Sixty-three percent (24 of 38) patients were less than the 10th percentile for height, and 55% (21 of 38) were less than the 5th percentile. Forty-nine percent (17 of 35) patients were less than the 10th percentile for weight, and 43% (15 of 35) were less than the 5th percentile. Leg bowing was present in 76.5% (26 of 34), and wrist/ankle swelling was present in 73.5% (25 of 34). A rachitic rosary was present in 41% (14 of 34) patients, and frontal bossing occurred in 23.5% (8 of 34).


View this table:
[in this window]
[in a new window]
 
TABLE 2. Baseline clinical features of the study population

 
Of the 43 children identified with nutritional rickets, presenting laboratory data before implementation of therapy was available for 36 children (Table 3Go). Hypocalcemia occurred in 55.6% (20 of 36) patients, as did hypophosphatemia. Alkaline phosphatase was elevated in 36 of 36 patients (100%). Secondary hyperparathyroidism was present in all 28 patients tested (100%).


View this table:
[in this window]
[in a new window]
 
TABLE 3. Baseline serum biochemistries of the study population

 
The mean serum level of 25-OHD was 20.9 ± 11.5 ng/ml (52.2 ± 28.7 nmol/liter; range, 4.7–55 ng/ml or 11.7 ± 137.3 nmol/liter). Serum levels of 25-OHD were below the normal lower reference range threshold of 15 ng/ml (37.4 nmol/liter) in 22% (6 of 27) patients. One patient receiving vitamin D supplements at the time of presentation had a 25-OHD level above the normal reference range. The mean serum 1,25-OH2D level was 114.8 ± 44.7 pg/ml (275.5 ± 107.3 pmol/liter). Serum levels of 1,25-OH2D were above the normal reference range for this population (30–90 pg/ml; 72 to 216 pmol/liter) in 61% (14 of 23) patients; in no patient was the 1,25-OH2D level below the normal reference range.

In exploration of the hypothesis that younger children may be more prone to vitamin D deficiency (during breast feeding) and older children more prone to calcium deficiency (after being weaned to low calcium diets), we examined the potential correlation between age at presentation and circulating 25-OHD level as well as time since weaning and circulating 25-OHD; neither of these correlations was significant. Furthermore, there was no difference in circulating 25-OHD between infants presenting during breast feeding (20.8 ± 2.4 ng/ml) and those presenting after weaning (21.0 ± 10.3 ng/ml), excluding any infants receiving vitamin D supplementation.


    Case Reports
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Case Reports
 Discussion
 References
 
Case 1

Patient A, a 24-month-old African-American girl, presented with tibial torsion and bowing of the lower extremities. She was born after a full-term gestation, weighing 7 lb, 3 oz, to a 22-yr-old Muslim mother who wore traditional covered dress. A was breastfed until 9 months of age and had never received any vitamin supplementation. A’s mother avoided dairy products due to symptoms of lactose intolerance, including bloating and diarrhea. Similarly, A was not fed milk and only occasionally ate cheese and yogurt, as the mother considered her to be lactose intolerant. In-toeing was noted by her mother at 1 yr of age; she had had several episodes of bronchospasm, but was otherwise healthy. One month before presentation, she was evaluated for wheezing and increased work of breathing. A rachitic rosary was noted on a chest radiograph.

A’s height was less than the 5th percentile for age, and her weight was at the 90th percentile for age. Evident features of rickets included frontal bossing, rachitic rosary, bowed legs, and swelling at the wrists and ankles, with mild tenderness. Serum calcium was 7.1 mg/dl (1.77 mmol/liter), phosphate was 3 mg/dl (0.97 mmol/liter), alkaline phosphatase was 2930 U/liter, PTH was 145 nlEq/ml, 25-OHD was 28.1 ng/ml (70.1 nmol/liter), and 1,25-OH2D was 110.5 pg/ml (265.2 pmol/liter). After establishment of the diagnosis, A was treated with vitamin D (150,000 IU, twice a day for 2 d) and 320 mg/d elemental calcium in divided doses.

Noncompliance hampered follow-up evaluation, and she was not reevaluated until 14 months later. At that time biochemical values had generally normalized: calcium, 10.5 mg/dl (2.62 mmol/liter); phosphate, 5.9 mg/dl (1.90 mmol/liter); alkaline phosphatase, 577 U/liter; PTH, 22 nlEq/ml; and 25-OHD, 29.3 ng/ml (73.1 nmol/liter). 1,25-OH2D values remained slightly elevated at 112.1 pg/ml (269.0 pmol/liter). Height had improved to the 10–25th percentile, while weight remained stable in the 75–90th percentile. Wrist and ankle swelling had improved. Calcium supplementation had continued, but no further administration of vitamins had been implemented.

Case 2

Patient B, a 24-month-old African-American boy, was referred with severe bowing, lower extremity muscle wasting, tibial torsion, and ankle deformities, which had been evident for approximately 1 yr. B was born after a full-term gestation, weighing 6 lb, 0 oz. He was breastfed for the first 15 months of life, with very little supplemental solid food and no vitamin supplementation. He sat at 9 months and walked at 20 months with difficulty. His diet at presentation included a variety of foods, but almost no dairy products. Because of the noted lower extremity abnormalities, B was referred to the pediatric endocrinology clinic. B’s father had undergone a partial parathyroidectomy several years previously. The mother reported a history of lactose intolerance and avoided dairy products. A 4-yr-old brother and 9-month-old sister were healthy.

Height and weight were less than the fifth percentile for age. Rachitic abnormalities of the distal radius, ulna, humerus, and tibia were evident. A rachitic rosary was present, and there was severe bowing of the legs. Serum calcium was 9.2 mg/dl (2.30 mmol/liter), phosphorus was 2.8 mg/dl (0.90 mmol/liter), alkaline phosphatase was 1640 U/liter, PTH was 115 nlEq/ml, 25-OHD was 34.1 ng/ml (85.1 nmol/liter), and 1,25-OH2D was 115.6 pg/ml (277.4 pmol/liter). The diagnosis of rickets due to nutritional deficiency was made, and he was placed on daily doses of 2000 IU vitamin D and 460 mg elemental calcium.

Within 1 month, PTH levels normalized to 19 nlEq/ml, and alkaline phosphatase levels decreased to 1440 U/liter. Height and weight percentiles increased in the subsequent 6 months, and there was radiographic improvement in bony abnormalities. Dietary intake of dairy products improved somewhat. However, 7 months after initiation of therapy, the alkaline phosphatase level had increased to 2130 U/liter. The family had recently discontinued calcium supplementation due to its expense. They had, however, continued the vitamin D supplement. Calcium therapy was resumed with a less expensive alternative preparation. Two weeks after resumption of calcium supplementation, alkaline phosphatase had fallen to 873 U/liter and eventually corrected entirely.

Case 3

Patient C, a 9-month-old African-American boy, was referred with a several-week history of poor gain in weight and height. The parents reported noticing bowing of the legs, but no aversion to weight bearing. He had been exclusively breast-fed, without any formula or vitamin supplementation, and was begun on baby food feedings approximately 1 month before the referral visit. A paternal uncle had leg bowing as a child, which was treated with orthopedic bracing. C’s length was slightly less than fifth percentile for age, and his weight was less than the fifth percentile for age. No craniotabes was evident, but widening of the wrist areas was noted. Minimal bowing of the legs was present. Radiographs were consistent with rickets (Fig. 1Go). Serum calcium was 8.8 mg/dl (2.20 mmol/liter), phosphorus was 2.2 mg/dl (0.71 mmol/liter), alkaline phosphatase was 1730 U/liter, PTH was 215 nlEq/ml, 25-OHD was 19.7 ng/ml (49.2 nmol/liter), and 1,25-OH2D was 51.3 pg/ml (123.1 pmol/liter). The urinary calcium/creatinine ratio was 0.04 mg/mg (0.11 µmol/µmol). The diagnosis of nutritional rickets was made, and he was placed on 575 mg elemental calcium daily, or approximately 85 mg/kg body weight·d. No vitamin D supplement was added, and laboratory values normalized over time as shown in Table 4Go. Treatment with calcium alone, with no vitamin D supplementation and no substantial change in circulating 25-OHD levels, resulted in healing of the rachitic abnormalities, as evidenced by follow-up radiographs, performed 3.5 months after the initial presentation (Fig. 1Go).



View larger version (130K):
[in this window]
[in a new window]
 
FIG. 1. Radiographs at presentation (left panel) and after 3 months of calcium therapy, with no supplemental vitamin D (right panel). Typical rachitic features, including metaphyseal widening and fraying of the metaphyseal edge, are apparent at the time of diagnosis; these features have considerably resolved at the time of the follow-up radiograph.

 

View this table:
[in this window]
[in a new window]
 
TABLE 4. Case 3: serum chemistry response to treatment with calcium

 

    Discussion
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Case Reports
 Discussion
 References
 
A review of recent medical literature strongly suggests that the number of cases of nutritional rickets is increasing. For example, in 1980, Edidin et al. (2) reported 10 cases of nutritional rickets within a 10-month period in Chicago, and Rudolf et al. (1) identified 4 cases in a 1-yr period in Hartford. In both groups of children, prolonged breastfeeding (>6 months) without vitamin D supplementation, vegetarian diet and/or poor dietary intake of dairy products, and dark skin pigmentation were cited as contributing factors. More recently, cases of nutritional rickets associated with these risk factors have been reported throughout the United States, including California (3), Washington (4), Alabama (5), Minnesota (6), New York (7), Vermont (8), Texas (9), North Carolina (10), and Georgia (11). The vast majority of these cases occurred in poor, urban, African-American children in the second year of life, who had been breastfed for longer than 6 months without vitamin D supplementation and who had been weaned to a diet severely lacking dairy products. These children exhibited the classic clinical and biochemical features of nutritional rickets. Subnormal serum 25-OHD levels were present in nearly all patients, indicating that vitamin D deficiency was the primary cause of rickets in these cases. All had complete or near-complete resolution of their rickets with vitamin D/calcium therapy. Although no data are available concerning the prevalence of nutritional rickets in the United States, the incidence of this condition appears to be increasing, especially in underserved populations.

This report documents a population with overt clinical, biochemical, and radiological evidence of nutritional rickets. In contrast to other reports, serum 25-OHD levels were well within the normal reference range in approximately three quarters of the children for whom measurements were available. We considered that some of these children may have been exposed to vitamin D before testing, thereby increasing 25-OHD levels into the normal range after development of disease. However, most cases presented between the late fall and early spring, a period of limited sunlight in the northeastern United States. The majority of patients were of African-American background and would have likely required significantly more sunlight than lightly pigmented persons to achieve the same elevations in 25-OHD levels (19). Furthermore, most children lived in urban settings, and it is unlikely that they would have had routine access to outdoor open play areas. Thus, it is doubtful that changes in exposure to vitamin D could have caused a significant increase in stores between the onset of disease and the time of testing in the bulk of this population.

We have also considered that these findings may reflect an inadequate definition of the lower normal limit for this population. Vitamin D stores are best assessed by measurement of serum 25-OHD levels, because it is the combined measurement of both endogenously synthesized vitamin D and that obtained from the diet. However, normal reference values for serum 25-OHD levels are problematic, because they vary depending on factors such as sunlight exposure, season, latitude, skin pigmentation, age, and dietary vitamin D intake. Although the lower threshold level of serum 25-OHD associated with increased risk for the development of rickets has been reported as ranging from 5 (20) to 10 ng/ml (12.5–25 nmol/liter) (21), more than half of our rickets patients had 25-OHD levels greater than 20 ng/ml (50 nmol/liter). When using the threshold value of 15 ng/ml for establishing the diagnosis of rickets, only 22% of the affected children were considered to have biochemical evidence of vitamin D deficiency. Nevertheless, it would be useful to establish physiological correlates of circulating 25-OHD levels in this age group to better interpret such values.

In contrast, circulating PTH values were elevated in all of the affected patients. At the present time there is only limited information available in normal children concerning the level of 25-OHD that is associated with secondary hyperparathyroidism, and the available data are not for this age group. In the setting of dietary calcium sufficiency, such a value would be of use as a physiological correlate of calcium absorption. The mean level of 25-OHD at normalization of PTH in our group of patients was 33.4 ± 16.1 ng/ml (83.4 ± 40.2 nmol/liter); however, this value was obtained in the context of healing rickets, not in the setting of normal homeostasis. Thus, elevated circulating PTH values, although not a specific marker for nutritional rickets, may serve as a sensitive biochemical indicator of dietary calcium deficiency (or malabsorption) in the setting of normal circulating 25-OHD levels.

It is possible that vitamin D requirements vary in different populations. One hypothetical explanation for such variation may relate to subtle changes in the function of the vitamin D receptor (VDR) secondary to polymorphisms/mutations in this protein. In several studies the VDR genotype has been associated with fractional calcium absorption (22, 23, 24). As vitamin D status, dietary calcium, and calcium absorption are the major factors regulating calcium availability, it follows that factors that affect calcium absorption may be important in determining a susceptibility to the development of rickets. Furthermore, dietary calcium and vitamin D requirements may differ among populations, and VDR genotype could potentially play a role in this variability. Thus, it is possible that individuals with certain polymorphisms of this receptor may be more susceptible to the development of metabolic bone disease if they are consuming a low calcium diet. Indeed, a correlation between VDR genotype and the presence of rickets in the Nigerian population has been reported (25).

Nutritional rickets due to calcium deficiency has been reported in Africa (26, 27, 28, 29) and in case reports from Western Europe (30) and North America (31). For example, Pettifor et al. (26) reported nine black children (age, 4.6–13 yr; mean, 9.4 yr) with nutritional rickets in rural South Africa. Despite having spent extensive time outdoors, these children had obvious clinical features of rickets, including progressive bone deformities, decreased growth, and radiographic changes consistent with the disorder. Four children had hypocalcemia, and all nine had elevated alkaline phosphatase and 1,25-OH2D levels, but normal 25-OHD levels. Calcium balance studies demonstrated that calcium absorption was not impaired. Treatment with calcium alone corrected the biochemical and radiographic abnormalities. In view of an environment providing plentiful vitamin D, but a diet severely lacking in calcium, the researchers concluded that calcium deficiency alone was the cause of nutritional rickets in these children.

Okonofua et al. (27) compared 10 Nigerian children with nutritional rickets and a diet low in calcium content and high in phytate content to 12 healthy age-matched controls. Serum calcium was lower, and alkaline phosphatase and PTH were elevated in the rachitic children, but 25-OHD, 1,25-OH2D, and osteocalcin levels did not differ significantly from control values. Treatment with calcium gluconate alone resulted in healing of their rickets.

In a randomized, double-blind, controlled trial, Thacher et al. (29) compared treatment of nutritional rickets in 123 Nigerian children with calcium alone, vitamin D alone, or the combination of calcium and vitamin D. The groups treated with calcium alone or combined calcium and vitamin D demonstrated a better healing response than the group treated with vitamin D alone. Baseline dietary calcium intake was similarly low in patients and a control group. The results of this study suggest that although calcium deficiency was an important contributor to nutritional rickets in these patients, other unidentified factors may have been involved in the development of their bone disease. As in their study, we found no correlation of 25-OHD level and age of presentation of rachitic disease in our North American population.

Based on our current experience and that reported by others, it is likely that a spectrum of pathogenetic mechanisms for the development of nutritional rickets exists (32) (Fig. 2Go). At one end of the spectrum are patients with pure vitamin D deficiency who have a sufficient dietary intake of calcium (point A). This may include many breastfed infants who are not supplemented with vitamin D as well as other infants with inadequate dietary vitamin D intake or limited sunlight exposure. At the other end of the spectrum are patients with a pure calcium deficiency (point B) due to low dietary calcium intake, yet with normal indices of vitamin D stores. These patients are described by our case reports and in the African studies mentioned above. A third group is likely to have marginal or low vitamin D stores and a diet deficient in calcium and/or high in substances that may impair intestinal absorption of dietary calcium (point C). Nutritional rickets patients from the Asian community in Great Britain (with low vitamin D stores and a diet with a high phytate/calcium ratio) typify this category (33). The majority of patients with nutritional rickets probably fall somewhere between the two ends of the spectrum, with a deficiency in either calcium or vitamin D playing a slightly more influential etiological role. We speculate that a greater supply of vitamin D may be necessary to compensate in such children for their suboptimal dietary calcium intake, and conversely, that increased calcium intake may be required to prevent disease in the setting of low normal 25-OHD levels. Therefore, in most patients both calcium and vitamin D are important for the treatment and prevention of nutritional rickets.



View larger version (21K):
[in this window]
[in a new window]
 
FIG. 2. The spectrum of nutritional rickets. See text for details.

 
In summary, approximately 50% of the patients described herein had serum 25-OHD levels above 20 ng/ml, yet manifest the classical biochemical, clinical, and radiographical features of nutritional rickets. The majority of children had stopped breast-feeding an average of 9 months before presentation and had been weaned to a diet low in dairy products. Thus, for many of these patients, inadequate calcium intake may have played an important role in the development of rickets. Moreover, requirements for vitamin D and calcium may be complementary; increased dietary calcium intake may be required to prevent rachitic disease in the setting of suboptimal 25-OHD levels. The current report emphasizes that nutritional calcium deficiency may occur in North American infants and is not limited to the setting of developing countries. Further investigation is called for to establish appropriate dietary guidelines for both calcium and vitamin D in infants.


    Footnotes
 
Abbreviations: 25-OHD, 25-Hydroxyvitamin D; 1,25-OH2D, 1,25-dihydroxyvitamin D; VDR, vitamin D receptor.

Received December 10, 2002.

Accepted April 10, 2003.


    References
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Case Reports
 Discussion
 References
 

  1. Rudolf M, Arulanantham K, Greenstein RM 1980 Unsuspected nutritional rickets. Pediatrics 66:72–76[Abstract/Free Full Text]
  2. Edidin DV, Levitsky LL, Schey W, Dumbovic N, Campos A 1980 Resurgence of nutritional rickets associated with breast-feeding and special dietary practices. Pediatrics 65:232–235[Abstract/Free Full Text]
  3. Hayward I, Stein MT, Gibson MI 1987 Nutritional rickets in San Diego. Am J Dis Child 141:1060–1062[Abstract]
  4. Feldman KW, Marcuse EK 1990 Nutritional rickets. Am Fam Physician 42:1311–1318[Medline]
  5. Bhowmick SK, Rettig KR 1991 Rickets caused by vitamin D deficiency in breast-fed infants in the southern United States. Am J Dis Child 145:127–130[Medline]
  6. Eugster EA, Sane KS, Brown DM 1996 Minnesota rickets. Minnesota Med 79:29–32
  7. Pugliese MT, Blumberg DL, Hludzinski J, Kay S 1998 Nutritional rickets in suburbia. J Am Coll Nutr 17:637–641[Abstract/Free Full Text]
  8. Fitzpatrick S, Sheard NF, Clark NG, Ritter ML 2000 Vitamin D-deficient rickets: a multifactorial disease. Nutr Rev 58:218–222[Medline]
  9. Shah M, Salhab N, Patterson D, Seikaly MG 2000 Nutritional rickets still afflicts children in North Texas. Tex Med 96:64–68
  10. Kreiter SR, Schwartz RP, Kirkman HN, Charlton PA, Calikoglu AS, Davenport ML 2000 Nutritional rickets in African American breast-fed infants. J Pediatr 137:153–157[CrossRef][Medline]
  11. Tomashek KM, Nesby S, Scanlon KS, Cogswell ME, Powell KE, Parashar UD, Mellinger-Birdsong A, Grummer-Strawn LM, Dietz WH2001 Nutritional rickets in Georgia. Pediatrics 107 URL: http://www.pediatrics.org/cgi/content/full/107/4/e45
  12. Ryan AS1997 The resurgence of breastfeeding in the United States. Pediatrics 99 URL: http://www.pediatrics.org/cgi/content/full/99/4/e12
  13. Hollis BW, Pittard III WB, Reinhardt TA 1986 Relationships among vitamin D, 25-hydroxyvitamin D and vitamin D-binding protein concentrations in the plasma and milk of human subjects. J Clin Endocrinol Metab 62:41–44[Abstract]
  14. American Academy of Pediatrics Committee on Nutrition 2001 The use and misuse of fruit juices in pediatrics. Pediatrics 107:1210–1213[Abstract/Free Full Text]
  15. Carpenter TO, Mitnick MA, Ellison A, Smith C, Insogna KL 1994 Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia. J Clin Endocrinol Metab 78:1378–1383[Abstract]
  16. Shepard RM, DeLuca HF 1980 Plasma concentrations of vitamin D3 and its metabolites in the rat as influenced by vitamin D3 or 25-hydroxyvitamin D3 intakes. Arch Biochem Biophys 202:43–53[CrossRef][Medline]
  17. Nesby-O’Dell S, Scanlon KS, Cogswell ME, Gillespie C, Hollis BW, Looker AC, Allen C, Doughertly C, Gunter EW 2002 Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr 76:187–192[Abstract/Free Full Text]
  18. Reinhardt TA, Horst RL, Orf JW, Hollis BW 1984 A microassay for 1, 25 dihydroxy vitamin D not requiring high performance liquid chromatography: application to clinical studies. J Clin Endocrinol Metab 58:91–98[Abstract]
  19. Clemens TL, Henderson SL, Adams JS, Holick MF 1982 Increased skin pigment reduces the capacity of the skin to synthesize vitamin D. Lancet 1:74–76[CrossRef][Medline]
  20. Parfitt AM 1994 Osteomalacia and related disorders In: Avioli LV, Krane SM, eds. Metabolic bone disease, 2nd Ed. San Diego: Academic Press; 329–396
  21. Haddad JG Jr 1992 Clinical aspects of the measurement of plasma vitamin D sterols and the vitamin D binding protein. In: Coe FL, Favus MJ, eds. Disorders of bone and mineral metabolism. New York: Raven Press; 195–216
  22. Ames SK, Ellis KJ, Gunn SK, Copeland CK, Abrams SA 1999 Vitamin D receptor gene Fok1 polymorphism predicts calcium absorption and bone mineral density in children. J Bone Miner Res 14:740–746[CrossRef][Medline]
  23. Wishart JM, Horowitz M, Need AG, Scopacasa F, Morris HA, Clifton PM, Nordin BE 1997 Relations between calcium intake calcitriol, polymorphisms of the vitamin D receptor gene, and calcium absorption in premenopausal women. Am J Clin Nutr 65:798–802[Abstract/Free Full Text]
  24. Dawson-Hughes B, Harris SS, Finneran S 1995 Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype. J Clin Endocrinol Metab 80:3657–3661[Abstract]
  25. Fischer PR, Thacher TD, Pettifor JM, Jorde LB, Eccleshall TR, Feldman D 2000 Vitamin D receptor polymorphisms and nutritional rickets in Nigerian children. J Bone Miner Res 15:2206–2210[CrossRef][Medline]
  26. Pettifor JM, Ross P, Wang J, Moodley G, Couper-Smith J 1978 Rickets in children of rural origin in South Africa: is low dietary calcium a factor? J Pediatr 92:320–324[CrossRef][Medline]
  27. Okonofua F, Gill DS, Alabi ZO, Thomas M, Bell JL, Dandona P 1991 Rickets in Nigerian children: A consequence of calcium malnutrition. Metabolism 40:209–213[CrossRef][Medline]
  28. Oginni LM, Worsfold M, Oyelami OA, Sharp CA, Powell DE, Davie MWJ 1996 Etiology of rickets in Nigerian children. J Pediatr 128:692–694[CrossRef][Medline]
  29. Thacher TD, Fischer PR, Pettifor JM, Lawson JO, Isichei CO, Reading JC, Chan GM 1999 A comparison of calcium, vitamin D, or both for nutritional rickets in Nigerian children. N Engl J Med 341:563–568[Abstract/Free Full Text]
  30. Legius E, Proesmans W, Eggermont E, Vandamme-Lombaerts R, Bouillon R, Smet M 1989 Rickets due to dietary calcium deficiency. Eur J Pediatr 148:784–785[CrossRef][Medline]
  31. Taylor A, Mandell G, Norman ME 1994 Calcium deficiency rickets in a North American child. Clin Pediatr 33:494–497
  32. Pettifor JM, Daniels ED1997 Vitamin D deficiency and nutritional rickets in children. In: Feldman D, Glorieux FH, Pike JW, eds. Vitamin D. San Diego: Academic Press; 663–678
  33. Henderson JB, Dunnigan MG, McIntosh WB, Abdul-Motaal AA, Gettinby G, Glekin BM 1987 The importance of limited exposure to ultraviolet radiation and dietary factors in the etiology of Asian rickets: a risk-factor model. Q J Med 63:413–425



This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
G. I. Baroncelli, A. Bereket, M. El Kholy, L. Audi, Y. Cesur, B. Ozkan, M. Rashad, M. Fernandez-Cancio, Y. Weisman, G. Saggese, et al.
Rickets in the Middle East: Role of Environment and Genetic Predisposition
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1743 - 1750.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
S. Hatun, A. Bereket, B. Ozkan, T. Cothkun, R. Kose, and A. Suha Calykothlu
Free vitamin D supplementation for every infant in Turkey
Arch. Dis. Child., April 1, 2007; 92(4): 373 - 374.
[Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
Picture of the Month--Diagnosis
Arch Pediatr Adolesc Med, September 1, 2006; 160(9): 984 - 985.
[Full Text] [PDF]


Home page
J. Nutr.Home page
S. Hatun, B. Ozkan, Z. Orbak, H. Doneray, F. Cizmecioglu, D. Toprak, and A. S. Calikoglu
Vitamin D Deficiency in Early Infancy
J. Nutr., February 1, 2005; 135(2): 279 - 282.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
P. Weisberg, K. S Scanlon, R. Li, and M. E Cogswell
Nutritional rickets among children in the United States: review of cases reported between 1986 and 2003
Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1697S - 1705S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. M Pettifor
Nutritional rickets: deficiency of vitamin D, calcium, or both?
Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1725S - 1729S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. Graff, T. D Thacher, P. R Fischer, D. Stadler, S. D Pam, J. M Pettifor, C. O Isichei, and S. A Abrams
Calcium absorption in Nigerian children with rickets
Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1415 - 1421.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
J Allgrove
Is nutritional rickets returning?
Arch. Dis. Child., August 1, 2004; 89(8): 699 - 701.
[Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
S Ladhani, L Srinivasan, C Buchanan, and J Allgrove
Presentation of vitamin D deficiency
Arch. Dis. Child., August 1, 2004; 89(8): 781 - 784.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeLucia, M. C.
Right arrow Articles by Carpenter, T. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeLucia, M. C.
Right arrow Articles by Carpenter, T. O.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals